| 31.33 -0.28 (-0.9%) | 04-17 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
Patterson Companies, Inc. specializes in distributing products essential for both dental and animal health sectors across the United States, Canada, and the United Kingdom. The company's operations are structured into three main divisions: Dental, Animal Health, and Corporate. The Dental segment supplies a wide array of expendable items such as infection control solutions, restorative materials, and instruments. It also provides both foundational and cutting-edge dental technology and equipment. Furthermore, this division offers comprehensive solutions designed to enhance practice efficiency, encompassing management software, e-commerce platforms, revenue cycle administration, patient interaction tools, and educational systems for clinicians and patients. Complementary services include software development and design, upkeep and servicing, and financial assistance for equipment acquisition. The Animal Health segment furnishes a broad spectrum of necessities, including biological agents, medications, immunizations, parasiticides, diagnostic tools, specialized diets (both prescription and over-the-counter), nutritional supplements, general supplies, equipment, and software. This segment also delivers various value-added services and markets its own exclusive product lines—Aspen, First Companion, and Patterson Veterinary—to serve veterinarians, livestock producers, and retail outlets. Through its Corporate segment, Patterson Companies facilitates financing for its clientele and markets various other distinct products. Its diverse customer base spans dentists, dental laboratories, healthcare institutions, and other medical practitioners, alongside veterinarians, animal care specialists, large-scale animal producers, and retailers specializing in animal health goods. The organization, which was established in 1877, was originally known as Patterson Dental Company before officially rebranding to Patterson Companies, Inc. in June 2004. Its corporate headquarters are situated in Saint Paul, Minnesota.
Tue, 07 Jul 2026
Patterson Companies looks beyond quiet tape as dental and animal health distributor builds on multi- - ad-hoc-news.de
Mon, 08 Jun 2026
Patterson Companies (PDCO) Q3 2025 earnings summary - Quartr
Tue, 22 Apr 2025
Patterson Companies Completes Acquisition by Patient Square Capital - Business Wire
Thu, 17 Apr 2025
Patterson completes merger, exits NASDAQ in $2.8B deal - Investing.com
Thu, 10 Apr 2025
Patterson Companies Merger: What Going Private with Patient Square Capital Means (PDCO Acquisition) - tradingcalendar.com
Tue, 01 Apr 2025
Patterson Companies, Inc. Shareholders Approve Acquisition by Patient Square Capital - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |
|
|
|
|
|
|
|
|
|